DGUOK and cystic fibrosis: Dubruc et al. reported C5b-9 that was expressed in 100% of GALD cases, yet also in 27% of non-GALD cases (enterovirus hepatitis, bile acid synthetic defect, DGUOK mutation, Gaucher disease, cystic fibrosis, and giant-cell hepatitis with autoimmune hemolytic anemia) (30).